Publication:
Effect of Time in Therapeutic Range on Cost and Clinical Outcomes of Atrial Fibrilation Patients: A Cost-Consequences Analysis of Rivaroxaban vs Warfarin for Turkey

dc.contributor.authorKockaya, G.
dc.contributor.authorCavus, F.
dc.contributor.authorOzin, B.
dc.contributor.authorYilmaz, K. C.
dc.contributor.authorCiftci, O.
dc.contributor.authorErgin, Oguzhan G.
dc.contributor.authorSaylan, M.
dc.date.accessioned2020-06-21T13:06:30Z
dc.date.available2020-06-21T13:06:30Z
dc.date.issued2018
dc.departmentOMÜen_US
dc.department-temp[Kockaya, G. -- Cavus, F.] CarthaGenetics, Pully, Switzerland -- [Ozin, B. -- Yilmaz, K. C. -- Ciftci, O.] Baskent Univ, Ankara, Turkey -- [Ergin, Oguzhan G.] 19 Mayis Univ, Samsun, Turkey -- [Sharaf, A.] CarthaGenetics, Pully, Turkeyen_US
dc.description.abstracten_US
dc.identifier.doi10.1016/j.jval.2018.09.617
dc.identifier.endpageS104en_US
dc.identifier.issn1098-3015
dc.identifier.issn1524-4733
dc.identifier.startpageS104en_US
dc.identifier.urihttps://doi.org/10.1016/j.jval.2018.09.617
dc.identifier.urihttps://hdl.handle.net/20.500.12712/11373
dc.identifier.volume21en_US
dc.identifier.wosWOS:000459985600535
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.journalValue in Healthen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleEffect of Time in Therapeutic Range on Cost and Clinical Outcomes of Atrial Fibrilation Patients: A Cost-Consequences Analysis of Rivaroxaban vs Warfarin for Turkeyen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files